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The mechanism of the cytotoxic effect exerted by parthenolide on tumor cells is not clearly deﬁned today. This article shows that
parthenolide stimulates in human osteosarcomaMG63 andmelanoma SK-MEL-28 cells a mechanism of cell death, which is not prevented
by z-VAD-fmk and other caspase inhibitors. In particular treatment with parthenolide rapidly stimulated (1–2 h) reactive oxygen species
(ROS) generation by inducing activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) and NADPH oxidase. This event caused
depletion of thiol groups and glutathione, NF-kB inhibition, c-JunN-terminal kinase (JNK) activation, cell detachment from thematrix, and
cellular shrinkage. The increase of ROS generation togetherwith themitochondrial accumulation ofCa2þ also favored dissipation ofDcm,
which seemed primarily determined by permeability transition pore opening, since Dcm loss was partially prevented by the inhibitor
cyclosporin A. Staining with Hoechst 33342 revealed in most cells, at 3–5 h of treatment, chromatin condensation, and fragmentation,
while only few cells were propidium iodide (PI)-positive. In addition, at this stage apoptosis inducing factor (AIF) translocated to the
nucleus and co-localized with areas of condensed chromatin. Prolonging the treatment (5–15 h) ATP content declined while PI-positive
cells strongly augmented, denouncing the increase of necrotic effects. All these effects were prevented byN-acetylcysteine, while caspase
inhibitors were ineffective. We suggest that AIF exerts a crucial role in parthenolide action. In accordance, down-regulation of AIF
markedly inhibited parthenolide effect on the production of cellswith apoptotic or necrotic signs. Taken together our results demonstrate
that parthenolide causes in the two cell lines a caspase-independent cell death, which is mediated by AIF.
J. Cell. Physiol. 228: 952–967, 2013.  2012 Wiley Periodicals, Inc.
Parthenolide, the major bioactive sesquiterpene lactone
present in Feverfew (Tanacetum parthenium), has recently
attracted considerable attention because of its complex
pharmacological action involving anti-microbial, anti-
inﬂammatory, and anti-cancer effects (Pareek et al., 2011).
Due to anti-inﬂammatory properties and low toxicity,
parthenolide is traditionally used to treat fever, headache,
rheumatoid arthritis, and menstrual irregularities (Pareek et al.,
2011). Its anti-inﬂammatory effect depends on the ability to
inhibit the transcriptional activity of nuclear factor-kB (NF-kB;
Pareek et al., 2011) and the enzymatic activities of 5-
lipoxygenase and cyclooxygenase (Sumner et al., 1992), which
are involved in inﬂammatory process.
In addition it has been shown that parthenolide may also
inhibit proliferation and induce death of several human cancer
cells in vitro, such as colorectal cancer (Zhang et al., 2004),
pancreatic cancer (Liu et al., 2010), multiple myeloma (Wang
et al., 2006), prostate cancer (Sun et al., 2010), metastatic
melanoma (Czyz et al., 2010), and cholangiocarcinoma (Kim
et al., 2005) cells. In comparison with its well-established anti-
inﬂammatory activity, the anti-tumor effect of parthenolide is
relatively less documented. Recent ﬁndings indicate that the
drug triggers apoptosis by inhibiting the activity of the pro-
survival transcriptional factor NF-kB or inducing generation of
reactive oxygen species (ROS).
NF-kB is a dimeric transcription factor, which has been
shown to promote survival of tumor cells and reduce the
effectiveness of cancer therapy (Bours et al., 2000; Ravi and
Bedi, 2004). This factor is bound to the Inhibitor kappa B (IkB)
protein in an inactive cytosolic complex. Phosphorylation of IkB
leads to the release of NF-kB, which translocates into the
nucleus where promotes the transcription of genes involved in
inﬂammatory response, as well as in regulation of cell
proliferation, apoptosis, and angiogenesis. Parthenolide has
been shown to inhibit phosphorylation of IkB, thus leading to
suppression of NF-kB activity (Kwok et al., 2001).
Many lines of evidence indicate that parthenolide induces
oxidative stress by increasing production of ROS (Wen et al.,
2002; Wang et al., 2006; Zunino et al., 2007). However, the
precise mechanism of parthenolide-induced oxidative stress
remains unclear, although recently it has been shown that
parthenolide can increase in prostate cancer cells ROS
generation by activating NADPH oxidase (NOX; Sun et al.,
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2010). ROS in its turn can be responsible for alteration of
mitochondrial function with the consequent activation of death
signaling pathways (Hampton and Orrenius, 1998) or can
induce the activation of c-Jun N-terminal kinase (JNK;
Shanmugam et al., 2010, 2011).
Finally, it has been ascertained that parthenolide prevents
resistance of tumor cells to TRAIL. In breast cancer cells this
sensitization involves activation of JNK (Nakshatri et al., 2004),
while in hepatocellular carcinoma cells parthenolide increases
the surface expression of death receptors TRAIL-R1 and R2
(Carlisi et al., 2011).
However, despite of the efﬁcacy shown by parthenolide in
the experiments in vitro, the drug exhibited in vivo only a
limited activity due to its poor solubility. Recently it has been
generated a dimethylamino analogueof parthenolide (DMAPT),
which improves solubility and bioavailability of the drug. This
compound has been employed successfully to eradicate acute
myelogenous leukemia stem cells (Guzman et al., 2007), and
also prostate (Shanmugam et al., 2010), lung and bladder
(Shanmugam et al., 2011) cancer cells in vivo. These results
authorize the inclusion of parthenolide in new therapeutical
strategies against cancer. Consequently a detailed knowledge of
the molecular mechanism induced by the sesquiterpene, either
when employed alone or in association, becomes necessary.
The aim of this article was to elucidate the mechanism of
parthenolide action on two lines of cancer cells, the human
osteosarcoma MG63, and the melanoma SK-MEL-28 cells, on
which parthenolide exerted its action inducing similar effects.
This article shows that the drug induced in the two cell lines a
caspase-independent form of death. After brief treatments
(1–3 h) the drug caused ROS generation, depletion of protein
thiols and glutathione (GSH) and dissipation of the
mitochondrial membrane potential (Dcm). These effects were
accompanied by condensation and fragmentation of chromatin.
For longer treatments necrotic signs became predominant
together with the fall of ATP level. Nuclear translocation of




Parthenolide was supplied by Sigma–Aldrich (Milan, Italy). Stock
solution of parthenolide was prepared in dimethyl sulfoxide
(DMSO) and diluted to ﬁnal concentration in the culture medium.
Final concentration of DMSO employed as vehicle never exceeded
0.04% and had no discernible effects on MG63 or SK-MEL-28 cells.
All reagents were purchased from Sigma–Aldrich, except for z-
VAD-fmk and DEVD-cho, which were supplied from Promega
(Milan, Italy), and IETD-fmk supplied from Clontech (Palo Alto,
CA).
Cell cultures
MG63 and SK-MEL-28 cells, obtained from ‘‘Istituto Scientiﬁco
Tumori’’ (Genoa, Italy), were grown as monolayers in culture
medium [DMEM supplemented with 10% (v/v) FCS and 2mM
glutamine] at 378C in a humidiﬁed atmosphere containing 5%CO2.
Cells were plated on 96 or 6-well plates or on 100-mm culture
dishes, then were allowed to adhere overnight in culture medium,
before the treatment with chemicals or vehicle only.
Cell viability and cell death assays
Cell viability was measured by the MTS method using the CellTiter
961 AQueous One Solution Cell Proliferation Assay (Promega)
according to the manufacturer’s protocol. Dehydrogenase activity
in the mitochondria of metabolically active cells converts MTS to
formazan, which is soluble in tissue culture medium. The
absorbance of the formazan was measured directly at 490 nm in a
96-well plate using an automatic ELISA plate reader (OPSYS MR,
Dynex Technologies, Chantilly, VA).
In order to determine either changes in nuclear morphology or
plasma membrane damage, the cells were stained with Hoechst
33342 and propidium iodide (PI), as suggested by Kelly et al. (2003).
In particular, cells (6 103/well) were at ﬁrst stained with Hoechst
33342 (2.5mg/ml medium) for 30min, washed with PBS,
resuspended in culture medium and treated for various times with
parthenolide. Then PI (2.0mg/ml medium) was added and the
incubation was protracted for additional 15min. At the end cell
morphology was visualized by a Leica DC 300F microscope
(Leicamicrosystems,Wetzlar, Germany) using appropriate ﬁlters to
examine Hoechst 33342 (DAPI ﬁlter with excitation wavelength of
372 nm and emissionwavelength of 456 nm) and PI (rhodamine ﬁlter
with excitation wavelength of 596 nm and emission wavelength of
620 nm). All the images were acquired by Leica Q Fluoro Software.
Apoptotic effects were also studied by ﬂow cytometry analysis
using the Annexin V-FITC/PI Apoptosis Detection Kit I (BD
Biosciences Pharmingen, San Diego, CA), according to the
manufacturer’s instructions. Fluorescence of the cells was analyzed
by a FACscan (Becton Dickinson, San Diego, CA).
Evaluation of ROS generation and mitochondrial
membrane potential
For ﬂuorimetric analysis MG63 cells (6 103/well) were treated
for 30min with 50mM 5-(and-6)-carboxy-20,70-
dichlorodihydroﬂuorescein diacetate (H2-DCFDA) ﬂuorescent
signal (Wang and Joseph, 1999). After washing parthenolide and
other effectors were added and the cells incubated for various
times. At the end the medium was removed and substituted with
PBS. Fluorimetric assays were performed in a multiwell
ﬂuorescence plate reader (Varian, Palo Alto, CA). The excitation
ﬁlter was set at 485 nm and the emission ﬁlter at 530 nm. In other
cases ﬂuorescence was directly visualized by means of a
ﬂuorescence microscope using a FITC ﬁlter.
In order to study the effect of parthenolide on mitochondrial
membrane potential, MG63 and SK-MEL-28 cells (6 103/well)
were treated for various times with parthenolide and other
effectors. At the end cells were treated for additional 15min with
JC-1 staining solution (Cao et al., 2007) and Dcmwas evaluated as
indicated in the assay protocol supplied by the Cayman Chemical
Company (Ann Arbor, MI). Cells were visualized by a ﬂuorescence
microscope. Healthy cells with polarized mitochondria were
detected using an appropriate ﬁlter to examine J-aggregates with
red-orange ﬂuorescence (rhodamine ﬁlter with excitation
wavelength of 596 nm and emission wavelength of 620 nm).
Unhealthy cells were detected using a ﬁlter to examine JC-1
monomers with green ﬂuorescence (FITC ﬁlter with excitation
wavelength of 485 nm and emission wavelength of 530 nm).
For all determinations ﬂuorescence was visualized bymeans of a
Leica DC 300F microscope (Leica microsystems), using the Leica
Q Fluoro Software.
Measurement of intracellular thiols and glutathione
In order to measure intracellular thiols, cells after the treatment
were detached, washed in PBS, and resuspended in 30mM Tris–
HCl, 3mM EDTA, pH 8.2. For determination of protein thiols
(Zhang et al., 2004) aliquots were added to 25ml of 1.5mMDTNB
(Ellman’s reagent) and 400ml methanol. After centrifugation at
3,000g for 5min, 250ml of each supernatant were transferred in a
96-well plate and read at 412 nm. For the analysis of free thiol
groups, aliquots were incubated with 25ml 10% TCA and
centrifuged. Fifty microliters of each supernatant were transferred
in a 96-well plate in the presence of 200ml 0.2M Tris–HCl, pH 8.9
and 20ml DTNB. Then the samples were read at 412 nm. The
absorbance was determined by an automatic ELISA plate reader.
The ﬁnal content of intracellular thiols was expressed as
nanomoles of SH groups per 105 cells.
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The intracellular GSH concentration was measured using a
commercial assay, provided by OXIS Research (Portland, OR).
After treatment, the cells (2 105/well) were harvested, and
centrifuged at 1,000g for 8min. The pellets werewashed in PBS and
resuspended in 50ml metaphosphoric acid (5 g/100ml distilled
water). GSHcontentwasmeasured as described bymanufacturer’s
instructions. Absorbance was read at 400 nm in a 96-well plate
reader. The content of intracellular GSH was expressed as
nanomoles of GSH per 105 cells.
NF-kB assay
NF-kB activity was evaluated by an ELISA-based assay (Trans-AM
NF-kB; ActiveMotif, Carlsbad, CA) as described bymanufacturer’s
protocol. Brieﬂy, nuclear extracts were prepared as previously
reported (Carlisi et al., 2011). Aliquots were placed in 96-well
plates pre-coated with the oligonucleotide containing the NF-kB
consensus sequence, and NF-kB activity was detected using a
speciﬁc antibody for p65 subunit provided by the kit.
Western blotting analysis
Cell lysates were prepared as previously reported (Giuliano et al.,
1999). Protein samples (30mg/lane) were subjected to SDS
polyacrylamide gel electrophoresis and then transferred to a
nitrocellulosemembrane for the detectionwith speciﬁc antibodies.
Analyses of phospho-JNK, Cytochrome c oxidase (COX IV) and
histone H1 were performed by using speciﬁc antibodies produced
by Santa Cruz Biotechnology (Santa Cruz, CA) while antibody for
AIF was provided by Abcam (San Francisco, CA). All the others
antibodies were purchased from Cell Signaling Technology
(Beverly, MA). Protein bands were detected by the Enhanced
chemiluminescence reagent (Pierce, Rockford, IL) and their
intensity was quantiﬁed by using Quantity One quantiﬁcation
analysis software (Bio-Rad, Hercules, CA). The correct protein
loading was ascertained by means of both red Ponceau staining and
immunoblotting for b-actin. All the blots shown are representative
of at least three separate experiments.
Measurement of adenosine triphosphate
Intracellular ATP was measured by using the ATP colorimetric/
ﬂuorimetric assay kit supplied by Abcam. Cells (2 105/well) were
lysed in 100ml of ATP assay buffer; then 10ml of 2Nperchloric acid
were added in order to remove proteins, followed by 20ml of
buffer containing 5M KOH and 3M KHCO3. After centrifugation
for 2min at 15,000g, 20ml of the supernatant were transferred to
96-well plate and developed according to the manufacturer’s
instructions. The absorbance was read at 570 nm using an
automatic ELISA plate reader.
Measurement of calcium level
Cytosolic calcium level was measured using Fluo-3AM (Sigma–
Aldrich; Zhang et al., 2004). Cells (2 105/well) were collected,
washed twice with cold calcium-free PBS and then incubated with
5mMFluo-3AM for 60min at 378C in darkness. Then the cells were
analyzed by ﬂow cytometry on a Beckman Coulter Epics XL ﬂow
cytometer (Brea, CA) using the Expo32 software.
Detection of cytochrome c and AIF
Cells (7 106/100-mm culture dish) were washed twice in PBS,
resuspended in lysis buffer (20mMHepes, pH7.5, 250mMsucrose,
1.5mMMgCl2, 10mMKCl, 1mMEGTA, 1mMEDTA, 1mMPMSF,
and protease inhibitors) and homogenized with a Teﬂon
homogenizer. In order to perform subcellular fractionation
homogenates were centrifuged at 1,000g for 10min at 48C. The
pellet was used to prepare the nuclear fraction (Carlisi et al., 2008).
The supernatant was centrifuged again at 10,000g for 30min; the
resulting pellet represented the mitochondrial fraction, while the
supernatant obtained, after a new centrifugation at 100,000g for 1 h
at 48C, represented the cytosolic fraction. The pellets for nuclear
and mitochondrial fractions were lysed and sonicated. Aliquots of
mitochondrial and cytosolic fractions were used to measure the
level of cytochrome c by an ELISA kit (Abnova, Taipei, Taiwan)
according to the manufacturer’s instructions. The absorbance was
read at 450 nm using an automatic ELISA plate reader. The content
of AIF was ascertained by western blotting analysis using 30mg of
proteins of the mitochondrial and nuclear fractions (Arnoult et al.,
2002). COX IV and histone H1 were used as mitochondrial and
nuclear markers, respectively.
In order to study the intracellular localization of AIF, cells
(6 103/well) were at ﬁrst treated with Hoechst 33342 (2.5mg/ml
medium) and then incubated with parthenolide for the established
times. At the end the cells were ﬁxed for 5min with 3%
paraformaldehyde, permeabilized for 5minwith 0.1%TritonX-100
and incubated with a blocking solution (PBS containing 1% BSA) for
1 h at room temperature and then with rabbit monoclonal
antihuman AIF antibody (Abcam) (1:100 in PBS) overnight at 48C,
followed by 2 h with 1:100 dilution of FITC-conjugated secondary
antibody (Santa Cruz Biotechnology). Finally, cells were visualized
with a Leica DC300F microscope with DAPI ﬁlter (excitation
wavelength of 372 nm and emission wavelength of 456 nm) and
FITC ﬁlter (excitation wavelength of 485 nm and emission
wavelength of 530 nm) for Hoechst and AIF, respectively.
Down-regulation of AIF by short interfering RNA (siRNA)
Cells were plated in a 6-well plate (7.5 104 cells/well) and
cultured in DMEM supplemented with 10% FBS for 24 h to reach
approximately 60–80% conﬂuence before transfection. For
silencing experiments, a speciﬁc siRNA directed against human AIF
(Santa Cruz Biotechnology) as a pool of double-stranded RNA
oligonucleotides was used. Brieﬂy, cells were transfected for 6 h
with 80 nM AIF siRNA in the presence of 5ml Metafectene Pro
(Biontex, Munich, Germany) in a ﬁnal volume of 1ml serum-free
DMEM. At the end, the reaction was stopped replacing the culture
medium with DMEMþ 10% FCS. Cells were examined for AIF
down-regulation and other properties 18 h after transfection. A
scramble siRNA was used as negative control.
Statistical analysis
Results are presented as means standard error. Data were
analyzed using the Student’s t-test.
Results
Parthenolide decreases cell viability and induces
cell detachment
Some preliminary experiments were performed to ascertain
the dose and the time dependence of the effect exerted by
parthenolide on the viability of MG63 and SK-MEL-28 cells. To
this end cells were treated for different times (2–15 h) with
various doses (10–100mM)of parthenolide and the viabilitywas
assessed byMTS assay. Thedose-dependence, studied at 15 hof
treatment (Fig. 1A), showed that the cytotoxic effect appeared
at 10mMparthenolide, when cell viability decreased by 15% and
25% for MG63 and SK-MEL-28 cells, respectively. Then viability
diminishedwith the doseof parthenolide so that at 25mMviable
cells lowered in the two lines to 25% and 15% of the control
values. Afterwards viability declined more slowly, reaching at
100mM parthenolide values of about 20% and 10% of the
controls. Therefore, the dose of 25mM was chosen for all the
experiments performed to investigate about the various effects
induced by parthenolide. The time course study (Fig. 1B)
showed that treatment with 25mM parthenolide rapidly
reduced cell viability and at 5 h of treatment the number of
viable cells fell to about 32% for MG63 cells and 19% for SK-
MEL-28 cells with respect to the related controls. Then viability
declined more slowly with the time, reaching at 15 h values of
about 25% and 15% of the controls.
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Fig. 1. The cytotoxic effect exerted by parthenolide on MG63 and SK-MEL-28 cells. A,B: Effects of parthenolide on cell viability. Cells were
treated with different doses of parthenolide for various times without or with 100mM z-VAD-fmk or 2mM NAC. Cell viability was assessed
by the MTSmethod according to the manufacturer’s instructions. A: Dose-dependence of the cytotoxic effect at 15 h of treatment. B: Time
course of the cytotoxic effect exerted by 25mM parthenolide. C: Morphologic changes of MG63 and SK-MEL-28 cells observed under light
microscopy at 200Tmagniﬁcation. Cells (6T 103/well) were treated for 2 or 4 h with 25mM parthenolide without or with 2mMNAC. In (A)
and (B) values are the means of three independent experimentsW SE. MP < 0.01 versus untreated control. In (C) the results are
representative of three independent experiments.
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The addition of 100mM z-VAD-fmk was ineffective in both
cell lines, whatever was the time and the dose employed, while
parthenolide effect was totally abolished by the addition of
2mM N-acetylcysteine (NAC).
Other preliminary experiments were performed to evaluate
morphological changes induced by parthenolide in MG63 and
SK-MEL-28 cells. Control cells displayed under light
microscopy (Fig. 1C) an adhesive and widened morphology.
Treatment for 2 h with 25mM parthenolide induced
detachment of a large percentage of cells (70–75%). Moreover
cells deprived of anchorage assumed soon a rounded shape.
Prolonging the time of treatment (4 h) most of cells showed a
remarkable reduction in cell volume. It is interesting to note
that when 2mM NAC was added together with parthenolide,
both MG63 and SK-MEL-28 cells maintained the adhesive
morphology. Therefore, NAC prevented cell detachment and
the successive shrinkage.
Fluorescence microscopy and ﬂow cytometric analysis of
parthenolide effects
In order to ascertain the mode of cell death induced by
parthenolide in MG63 and SK-MEL-28 cells we analyzed by
ﬂuorescence microscopy the effects of the drug in cells stained
with Hoechst 33342 and PI.
Hoechst 33342 penetrates the plasma membrane and emits
blue ﬂuorescence when bound to DNA. Therefore, cells
showing chromatin condensation (CC) in their nuclei have
stronger blue ﬂuorescence when compared to control cells
(Kelly et al., 2003). Instead PI is a cell-impermeable nuclear dye
which stains the nuclei of the cells (red ﬂuorescence) that have
lost plasma membrane integrity and are considered to be
necrotic.
Figure 2A shows merged images at 100 magniﬁcation
related to the effects induced by parthenolide treatment at 3
and 12 h in both cell lines. Highermagniﬁcation (400) ofMG63
cells permitted to observe (Fig. 2B) at 3 h of treatment the
presence of PI-negative cells which exhibited positivity to
Hoechst, nuclear shrinkage and CC. In addition many of these
cells also exhibited chromatin fragmentation. At 12 h of
treatment a high percentage of cells showed pink ﬂuorescence
since the loss of membrane integrity allowed PI to enter the
cells, which thereforewere stainedwith both the dyes. Identical
observations were made for SK-MEL-28 cells (not shown).
Time course experiments performed for both cell lines
(Fig. 2C) showed that in the ﬁrst phase of treatment (0–5 h) the
number of cells, which exhibited brilliant blue ﬂuorescence and
chromatin condensation (CC cells), rapidly rose, reaching at 5 h
a percentage of about 85%. Instead in this phase only a limited
number of cells appeared positive to PI (15–25% at 5 h).
Prolonging the time of treatment (5–15 h) the number of PI-
positive cells showing pink ﬂuorescence (PF cells) progressively
increased so that at 15 h PF cells reached 60% and 72% of the
total cells counted in the ﬁeld for MG63 and SK-MEL-28 cells,
respectively.
Themodiﬁcations induced by parthenolide treatment in both
cell lines were not prevented by the addition of 100mMz-VAD-
fmk, a general inhibitor of caspases (Fig. 2A), or other caspase
inhibitors, such as DEVD-cho (100mM) or IETD-fmk (10mM)
(not shown), whatever was the time of treatment. Instead our
results show that 2mM NAC abolished parthenolide effects
during 15 h of treatment (not shown).
In addition we evaluated, using Annexin V-FITC/PI staining
method, whether the cytotoxic action of parthenolide was
associated with the exposure of phosphatidylserine on the cell
membrane. For these experiments cells were treated for
various times (5, 8, 12, and 15 h) with 25mM parthenolide.
Then, 5 103 cells per sample were analyzed by FACscan ﬂow
cytometer. As shown in Figure 3, treatment for 5 h did not
increase in both cell lines the percentage of cells with early
apoptotic signs (C4 area). Prolonging the time of treatment the
population of cells that underwent necrosis (PI-positive cells,
C1 area) was progressively increased, reaching at 15 h levels of
about 53% and 60% forMG63 and SK-MEL-28 cells, respectively
(Fig. 3).
Parthenolide stimulates ROS generation
To ﬁnd the cause of the rapid inhibitory action exerted by
parthenolide on cell viability we examined the effect of the drug
on the production of ROS in the two cell lines. As shown in
Figure 4A, ﬂuorimetric assays demonstrated that parthenolide
rapidly induced production of ROS. Treatment with 25mM
parthenolide stimulated in both cell lines ROS generation
already at 30min of treatment, while the maximum effect was
observed at 2 h.
In agreement with this ﬁnding also ﬂuorescence microscopy
showed that parthenolide rapidly induced ROS generation in a
high percentage of treated cells. In fact, as shown in
Figure 4B, most of MG63 cells, pre-treated with the
ﬂuorochrome H2-DCFDA, exhibited green ﬂuorescence
already at 1 h of treatment with parthenolide. Identical results
were obtained for SK-MEL-28 cells (not shown).
Parthenolide effect on ROS generation was inhibited by a
treatment with different antioxidants, NAC, apocynin,
diphenyleneiodonium (DPI), and rotenone (Fig. 4B,C). NAC is
an effective scavenger for free radicals. Apocynin and DPI
prevent the production of superoxide anion through the
inhibition of NOX (Wu et al., 2008), whereas rotenone is
known to reduce the production of ROS by inhibiting the
mitochondrial electron transport system (Batandier et al.,
2006). Such an effect of parthenolide was also diminished by the
inhibitor of extracellular signal-regulated kinase 1/2 (ERK 1/2)
U0126 (Dewas et al., 2000; Satoh et al., 2000). ERK 1/2 is a
kinase which has been shown to enhance NOX-1 transcription
(Moon et al., 2010). Moreover our article demonstrates,
according to previous reports of other authors (Kurdi and
Booz, 2007; Kurdi et al., 2007), that brief treatments (1–4 h)
with parthenolide stimulated in both cell lines phosphorylation
and activation of ERK 1/2 (Fig. 4D). Therefore, it seems likely
that also U0126 can inhibit parthenolide effect on ROS
generation through a reduction of NOX activity.
The results of our experiments for both cell lines show
(Fig. 4B,C) that NAC was the most effective inhibitor, since it
annulled parthenolide effect on ROS generation. At 1 h of
treatment the highest effect, apart from NAC, was exerted by
apocynin and DPI, which reduced the cells showing green
ﬂuorescence by 60%, followed byU0126 (45%), and rotenone
(40%). However this last compound was shown to be more
effective than apocynin, DPI, and U0126 when the cells were
treated with parthenolide for longer periods of time (4 h,
Fig. 4C). At last ROS generation was not prevented by caspase
inhibitors (not shown).
Finally, we investigated whether ROS generation can be
correlatedwith the activation of autophagicmechanism. To test
this possibility cells were treated with parthenolide and then
incubated with 50mMmonodansylcadaverine (MDC) in PBS at
378C for 15min. At the end the mediumwas replaced with PBS
and the cells were analyzed by ﬂuorescence microscopy. The
analysis suggested that parthenolide did not induce the
production of autophagic vacuoles in both cell lines (not
shown). Therefore, it seems that autophagy is not involved in
parthenolide-induced cell death.
Parthenolide causes depletion of intracellular thiols
The ﬁnding that parthenolide rapidly caused ROS generation
suggested to us, in accordance with Zhang et al. (2004), that the
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Fig. 2. Fluorescencemicroscopic images showing theeffectsofparthenolide treatmentafterHoechst33342andPI staining.MG63andSK-MEL-
28 cells (6T 103/well) were stained with Hoechst 33342 (2.5mg/ml medium; blue ﬂuorescence) and then treated with 25mM parthenolide for
various times. At the end the cells were incubated for additional 15min with PI (2.0mg/ml medium; red ﬂuorescence). Cell morphology was
visualized with a Leica DC 300F microscope with ﬂuorescent ﬁlters for DAPI and rhodamine. A: Merged images at 100Tmagniﬁcation of both
MG63andSK-MEL-28cells treatedwithparthenolide for3and12hwithoutorwith100mMz-VAD-fmk.B:Merged imagesat400Tmagniﬁcationof
MG63 cells. a: Cells treated with parthenolide for 3 h. The image shows cells with condensation and fragmentation of chromatin. b: Cells treated
withparthenolide for12 hshowingPFandsignsofbothapoptosisandnecrosis.C:Timecoursestudyshowingmorphologicalmodiﬁcations induced
byparthenolide inMG63andSK-MEL-28cells.CCcells, cellscontainingcondensedchromatin,eithernegativeorpositivetoPI;PFcells,PI-positive
cellswith both PFand condensed chromatin. Cells were counted in three differentmicroscopic ﬁelds in eachwell (threewells per treatment) and
expressed as percentage of the total number of cells counted in the ﬁeld. In (A) and (B) the results are representative of three independent
experiments. In (C) values are the means of three independent experimentsWSE. MP<0.01 versus untreated control.
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drug through the production of ROS can induce a depletion of
SH groups. Therefore, we examined the effect of parthenolide
on the intracellular levels of protein thiols, free thiols, and free
GSH in both MG63 and SK-MEL-28 cells. Time course
experiments (Fig. 5A) showed that these levels rapidly
diminished with the time so that in MG63 cells at 3 h of
treatment the content of protein thiols was reduced to about
30% of the control, while free thiols andGSH decreased to only
14% and 10%, respectively. Similar results were found for SK-
MEL-28 cells. Low doses of NAC (150mM) completely
prevented the cells of both the lines from the depletion of
intracellular thiols (Fig. 5B) and GSH (not shown), while both
apocynin and U0126 as well as rotenone exhibited partial
preventive effects (Fig. 5B).
The effects of parthenolide on NF-kB and JNK activities
Several lines of evidence suggest that NF-kB induces the
expression of target genes that regulate apoptosis and facilitate
survival of tumor cells as well as angiogenesis and metastasis.
Therefore the inhibition of NF-kB in cancer cells represents
one of the major strategies in anticancer therapy (Olivier et al.,
2006). Furthermore, it has been established that JNK plays a
role in cell death induced by oxidative stress. Finally many
authors have shown that parthenolide in several tumor cells
inhibits NF-kB activity and induces JNK activation (Shanmugam
et al., 2010, 2011). On the basis of these considerations we
investigated whether the drug exerted any effect onNF-kB and
JNK activities in MG63 and SK-MEL-28 cells. Time course
experiments showed that 25mM parthenolide markedly
decreased theDNA-binding activity of p65, a component ofNF-
kB, in both cell lines (Fig. 6A). Parthenolide effect was very rapid
since after 2 h of incubation the level of p65 activity lowered to
only 20% of control.
Moreover, as shown in Figure 6C, parthenolide stimulated in
both cell lines phosphorylation and activation of JNK. The effect
was observed already at 2 h and increased at 5 h of treatment. It
is interesting to note that 2mM NAC completely prevented
both the depletion of p65 activity (Fig. 6B) and the activation of
JNK (Fig. 6C).
The effect of parthenolide on mitochondrial
membrane potential
It is well known thatmitochondrial permeability transition pore
(PTP) is located at the innermitochondrial membrane.Opening
of this pore, as a consequence of oxidation of redox-sensitive
components, results in mitochondrial permeability transition
and dissipation of mitochondrial membrane potential (Dcm). It
is well known that PTP is constituted by adenine nucleotide
translocase (ANT) in the inner membrane (Crompton, 1999)
and cyclophilin D (Cyp D) in the matrix (Crompton, 1999;
Baines et al., 2005). Cyp D induces PTP opening, favoring
conformational change dependent on Ca2þ, whereas the
inhibitor of pore opening cyclosporin A (CsA) interacts with
Cyp D reducing sensibility of pore opening to Ca2þ (Chernyak
and Bernardi, 1996; Javadov et al., 2009). Furthermore, the
voltage-dependent anion channel (VDAC) is located in the
outermitochondrial membrane.Oligomerization of VDACand
the successive interaction with Bax can induce the production
of pores permeable to apoptotic factors (Scharstuhl et al., 2009;
Shoshan-Barmatz et al., 2010). Such an event can be inhibited
by 4,40-diisothiocyanostilbene-2,20-disulfonic acid (DIDS), as
reported by Keinan et al. (2010).
Fig. 3. Flow cytometric analysis of parthenolide effect onMG63 andSK-MEL-28 cells. Cells were treatedwith 25mMparthenolide for 5 and 15h.
1T 105 cells of each sample were double stained with Annexin V/PI, as reported in methods, and 5T 103 cells per sample were analyzed by ﬂow
cytometry. The C1 area represents cell necrosis, the C2 area represents late apoptosis, the C3 area represents the living cells and the C4 area
represents early apoptotic cells. The results are representative of three independent experiments.
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Fig. 4. ParthenolideinducesROSgeneration.A:Fluorimetricanalysis showingthetimecourseofparthenolide-inducedROSgeneration inMG63
and SK-MEL-28 cells. Cells (6T 103/well) were treated with 50mMH2-DCFDA ﬂuorescent signal and then with 25mM parthenolide for various
times. Fluorimetric assays were performed in amultiwell ﬂuorescence plate reader at 485 nm (excitation ﬁlter) and 530 nm (emission ﬁlter). B:
Images of ﬂuorescencemicroscopy showingROSgeneration determinedby parthenolide.MG63 cells (6T 103/well) were treatedwith 50mMH2-
DCFDA ﬂuorescent signal and then for 1 h with 25mM parthenolide without or with NAC, apocynin, DPI, U0126, or rotenone. Oxidation of the
ﬂuorochrome produces green ﬂuorescence, which was visualized with a Leica DC 300Fmicroscope at 100Tmagniﬁcation using a FITC ﬁlter. C:
Percentages of cells with green ﬂuorescence after treatment of MG63 cells with parthenolide for 1 or 4 h. The inﬂuence of NAC, apocynin, DPI,
U0126,androtenoneonROSgeneration inducedbyparthenolide.Cellswithgreenﬂuorescencewerecounted inthreedifferentmicroscopicﬁelds
in eachwell (threewells per treatment) and expressed as percentageof the total number of cells countedunder lightmicroscopy.D:The effect of
parthenolide on the level of phospho-ERK 1/2. Cells (2T105/well) were treated for various times with parthenolide without or with U0126. Cell
lysateswereimmunoblottedanddetectedwithanantibodyrecognizingphospho-ERK1/2. In(A)and(C)valuesarethemeansofthreeindependent
experimentsWSE. MP<0.01 versus untreated control. MMP<0.01 versus parthenolide-treated cells. In (B) and (D) the results are representative of
three independent experiments.
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The ﬁndings that parthenolide stimulated ROS generation
and caused depletion of intracellular thiols suggested to us,
in agreement with Wen et al. (2002), that the drug can
induce dissipation of Dcm. Therefore, we studied the effect
of parthenolide on Dcm by using the ﬂuorescent cationic
dye JC-1. To this end MG63 and SK-MEL-28 cells were
treated with 25mM parthenolide for various times and
then with JC-1 for additional 15min. At the end
ﬂuorescence was visualized by a Leica microscope. It was
possible to observe that after brief treatments (1–3 h) JC-1
ﬂuorescence shifted from red-orange (J-aggregates) to
green (JC-monomer form), indicating dissipation of Dcm
(Fig. 7A).
Figure 7B shows a time course experiment concerning the
effect of parthenolide onMG63 and SK-MEL-28 cells.Dcmwas
expressed as a ratio between cells with brilliant red
ﬂuorescence (J-aggregates) and cells with brilliant green
ﬂuorescence (JC-1monomers) (red/green ﬂuorescence). In the
presence of parthenolide this ratio rapidly lowered to about
20% of control at 1 h and 10% at 2 h of treatment. Such an effect
was prevented by the addition of 2mM NAC (Fig. 7C).
Moreover 10mM CsA partially prevented parthenolide-
Fig. 5. Parthenolide induces depletion of intracellular thiols andGSH.A: Time course study of the decreasing effect induced by parthenolide on
protein thiols, free thiols, and freeGSHinMG63andSK-MEL-28 cells.Cells (2T 105/well)were treated for various timeswith25mMparthenolide.
B:The effect ofNAC, apocynin,U0126, and rotenoneon the depletionof protein thiols induced inMG63 andSK-MEL-28 cells by treatment for 2 h
withparthenolide.Protein thiols, free thiols, and freeGSHweredeterminedusing colorimetric assays, as reported inMethodsSection.Values are
the means of three independent experimentsWSE. MP<0.01 versus untreated control.
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induced depolarization, increasing the ratio ‘‘red/green
ﬂuorescence’’ from 10% to 50% of control, while a minor effect
was exerted by 300mM DIDS. These results (Fig. 7A,C)
strongly suggested that parthenolide-induced depolarization
can be considered as a consequence of events primarily
determined at the inner mitochondrial membrane.
Because it has been suggested that mitochondrial Ca2þ
accumulation plays a role in the induction of PTP opening, we
examined the effect of RU360, a selective inhibitor of the
mitochondrial calcium uptake system (Garcia-Rivas et al.,
2006). As reported in Figure 7C, 10mM RU360 partially
prevented parthenolide-induced depolarization. Therefore, we
concluded that dissipation of Dcm was favored by calcium
overload.
Finally, parthenolide effect on Dcm was not prevented by
caspase inhibitors (not shown).
The effects of parthenolide on ATP and cytosolic
calcium level
The effect exerted by 25mM parthenolide on the intracellular
ATP content was studied in both MG63 and SK-MEL-28 cells
during 15 h of treatment (Fig. 8A). Until the ﬁfth hour of
treatment ATP level was not modiﬁed by the drug. Then ATP
content progressively decreased and at 15 h of treatment the
level of ATP, expressed as nmol/100mg of protein, lowered in
MG63 cells from the value of 3.5 in the untreated control to 0.7
in treated cells (80%). Similarly in SK-MEL-28 cells ATP level
Fig. 6. The effects of parthenolide onNF-kBand JNK activity. A: Time course study of the parthenolide effect onDNA-binding activity of p65, a
member of NF-kB. Cells were treated for various times with 25mM parthenolide. The binding was quantiﬁed in nuclear extracts of MG63 and
SK-MEL-28cellsbyanELISAassayasreported inMethodsSection.B:NACpreventedparthenolideeffectonp65binding.Cellsweretreated for2 h
with parthenolide and various doses of NAC. C: Parthenolide stimulated phosphorylation of JNK, while NAC prevented this effect. MG63 and
SK-MEL-28 cells (2T 105/well)were treated for 2or 5 hwith 25mMparthenolidewithout orwithNAC.At theend cell extractswereprepared and
submitted towesternblottinganalysis.Detectionwasperformedbyusinganantibodyagainstphospho-JNK. In (A)and (B)valuesare themeansof
three independent experimentsWSE. MP<0.01 versus untreated control. In (C) the results are representative of three independent experiments.
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diminished from the value of 2.2 in the control to only 0.4 in
treated cells (82%).
As shown in Figure 8B, treatment with 25mM parthenolide
induced a remarkable increase in the level of cytosolic calcium
both in MG63 and SK-MEL-28 cells. The effect was very rapid
because was observed already at 1 h of treatment.
Parthenolide induces mitochondrial release of
cytochrome c and decreases the expression of
pro-caspases-3 and 8
A consequence of Dcm dissipation in the mechanism of
apoptosis is the release from mitochondria of some proteins,
such as cytochrome c, AIF or Smac/DIABLO. It is well known
that cytochrome c, when is released into the cytosol interacts
withAPAF-1, pro-caspase-9 and dATP to form the apoptosome
(Reubold and Eschenburg, 2012). This complex activates
caspase-9, which in turn activates the effector caspase-3. Since
parthenolide caused disruption of mitochondrial membrane
potential, we performed some experiments to ascertain
whether the drug stimulated the release of cytochrome c.
MG63 and SK-MEL-28 cells were treated for 3 h with 25mM
parthenolide. At the end the cells were homogenized and the
subcellular fractions were prepared as reported in Methods. By
means of an ELISA assay it was possible to demonstrate that
parthenolide increased the content of cytochrome c in the
cytosolic fraction while a concomitant decrement was
observed in the mitochondria (Fig. 9A).
We investigated by means of western blotting analysis
whether parthenolide exerted some effects on the expression
of pro-caspases and on the production of their active forms. As
shown in Figure 9B, parthenolide treatment markedly
decreased in both cell lines the level of both pro-caspase-8 and
pro-caspase-3. These effects were already observed at 3 h of
treatment and became more consistent at 5 h. Instead the level
of pro-caspase-9 was not modiﬁed. Antibodies employed for
this analysis detect both the full-length forms of caspases and
the active fragments resulting from cleavage. However, for the
three caspase activities it was not possible to observe the
production of the cleaved and active forms not only at 3 and 5 h
(Fig. 9B), but also when the treatment was prolonged to 10 and
15 h (not shown).
Parthenolide induces mitochondrial release of AIF and
its co-localization with DNA
It is well known thatAIF is a caspase-independent death effector
(Baritaud et al., 2010), which after mitochondrial release
translocates to the nucleus, where induces CC and DNA
fragmentation (Jin and El-Deiry, 2005). Therefore, we
performed some experiments in order to ascertain whether
parthenolide stimulates the release of AIF from mitochondria.
Western blotting analysis showed that after 3 h of treatment
with 25mM parthenolide AIF level decreased in the
mitochondria while it increased in the nuclear fraction
(Fig. 10A). These results suggested that parthenolide
determined as a consequence of mitochondrial depolarization
the release of both cytochrome c and AIF.
Then we investigated whether parthenolide treatment
stimulated co-localization of AIF with DNA. The cells were
stained with Hoechst 33342 for DNA and with an anti-AIF
antibody suitable for the detection of endogenous AIF. In
untreated cells AIF was clearly localized in extranuclear sector,
whereas in parthenolide-treated cells AIF migrated to the
nucleus and co-localized with areas of condensed chromatin.
Figure 10B shows co-localization of AIF with DNA, which was
observed after treatment for 3 h with 25mM parthenolide
either in MG63 and SK-MEL-28 cells. These results were not
modiﬁed by the addition of 100mM z-VAD-fmk (not shown).
Transfection of cells with AIF siRNA reduces the
cytotoxic effects induced by parthenolide
In order to ascertain whether AIF takes part in the cytotoxic
effect exerted by parthenolide we have transiently transfected
both MG63 and SK-MEL-28 cells with AIF siRNA. After
transfection for 6 h the incubation was protracted for other
18 h. Western blotting analysis (Fig. 11A) revealed that this
procedure caused down-regulation of AIF, which diminished by
about 70% in both MG63 and SK-MEL-28 cells, while AIF level
remained constant in the control cells, which were transfected
with scramble siRNA.
When AIF-silenced cells of both the lines were treated
for 2–4 h with 25mM parthenolide a minor number of cells
(40 to 50%) with condensed chromatin (CC cells) was
Fig. 7. The effects of parthenolide on mitochondrial membrane
potential. A: Parthenolide induced mitochondrial depolarization in
MG63 and SK-MEL-28 cells. Cells (6T 103/well) were treated for 2 h
with 25mMparthenolidewithout orwithCsAorDIDS.At the end the
ﬂuorochrome JC-1 was added for additional 15min. Depolarization
was indicated by the shift of ﬂuorescence from red-orange to
greenish. Fluorescent cells were visualized with a Leica DC 300F
microscope at 200T magniﬁcation with ﬂuorescent ﬁlters for FITC
and rhodamine. Application of CsA or DIDS partially inhibited the
effect of parthenolide. B: The effect exerted in MG63 cells by
parthenolide on mitochondrial membrane potential, expressed as a
ratio of J-aggregate to JC-monomer (red/green ﬂuorescence). Time
course study of the effect induced by 25mM parthenolide. C: NAC,
CsA, DIDS, and RU360 partially prevented the effect exerted by
treatment for 2 h with parthenolide. In (A) the results are
representative of three independent experiments. In (B) and (C)
values are the means of three independent experimentsWSE.
MP<0.01 versus untreated control. MMP<0.01 versus parthenolide-
treated cells.
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observed in comparison with control cells transfected with a
scramble siRNA (Fig. 11B). Similarly after longer periods of
treatment (10–15 h) the percentages of cells exhibiting PF
diminished in AIF-silenced cells with respect to the controls
(Fig. 11B). The results suggested that AIF can be considered as
an effective mediator of parthenolide action.
Discussion
Although many authors have investigated about the anti-
tumor action of parthenolide, the modalities through which
this drug induces cell death are not clearly deﬁned at the
moment.
It is well known that cell death can be determined by two
different mechanisms, apoptosis or necrosis. Apoptosis (Jin and
El-Deiry, 2005) is an active process of programmed cell death,
which can be triggered in tumor cells by a number of different
stimuli, such as stimulation of death receptors, DNA damage
and oxidative stress. Apoptosis displays cell shrinkage, CC and
fragmentation, production of apoptotic bodies, and sequential
activation of multiple caspases. Instead classic necrosis
(Golstein and Kroemer, 2007) is a passive process,
Fig. 8. The effects of the parthenolide on the levels of ATP and intracellular Ca2R. A: Parthenolide induced depletion of ATP level. Time course
studyoftheparthenolideeffectonthe intracellularcontentofATPboth inMG63andSK-MEL-28cells.Cells (2T 105/well)weretreatedwith25mM
parthenolide for various times. At the end extracts were prepared and ATPwas assayed bymeans of a colorimetric procedure. B: Parthenolide
increasedintracellularCa2R level.MG63andSK-Mel28cells(2T 105/well)weretreatedwith25mMparthenolidefor1,2,or5 h.Attheendcellswere
loaded with Fluo-3 AM for 60min and then immediately analyzed using ﬂow cytometry. In (A) values are the means of three independent
experimentsWSE. MP<0.01 versus untreated control. In (B) the results are representative of three independent experiments.
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characterized by disruption of cellular plasma membrane and
extensive cellular swelling. Recently it has been shown that also
necrosis can be considered as a programmedmechanism of cell
death (Artus et al., 2010; Baritaud et al., 2010), but independent
on caspase activities. However, at the moment a distinction
between apoptosis and necrosis on the basis of the dependence
on caspase activities is not certain, because other caspase-
independent mechanisms of programmed cell death have been
recently described, some of which exhibit necrotic-like aspects,
whereas others show apoptotic-like characteristics (Tait and
Green, 2008).
Although previous studies report that parthenolide induces
cell death in a number of tumor cells by a caspase-dependent
mechanism (Steele et al., 2006; Liu et al., 2010), our article
shows for the ﬁrst time that parthenolide stimulated in human
osteosarcomaMG63 andmelanoma SK-MEL-28 cells a caspase-
independent mechanism. In particular parthenolide induced in
the ﬁrst phase of treatment (0–5 h) in most of cells of both the
lines condensation of chromatin while only a few cells were PI-
positive. Moreover, cells assumed a rounded shape, showed a
substantial reduction of their volume and appeared detached
from substrate. In the second phase of treatment (5–15 h) a
progressive increase in the percentages of PI-positive cells was
observed, suggesting that extensive damage of cellular plasma
membranes occurred only after long periods of treatment. All
these events depended on oxidative stress because were
prevented by NAC, whereas they were caspase-independent
since z-VAD-fmk and other caspase inhibitors were unable to
modify them.
Our results suggest that oxidative stress played a central role
in both cell lines in the mechanism of parthenolide action. The
drug strongly induced ROS generation already in the ﬁrst 2 h of
treatment. Such an effect, in accordance with Sun et al. (2010),
was primarily dependent on the activation of NOX, since it was
efﬁcaciously prevented by apocynin and DPI. The role of
mitochondrial respiratory chain was predominant at 4 h of
treatment, when rotenone resulted to be the best inhibitor of
parthenolide effect.
In the ﬁrst hours of treatment ROS generation was
responsible for a series of events which caused toxic effects in
the cells. In particular parthenolide induced in both cell lines a
marked depletion of the intracellular level of free thiols, protein
thiols, and free GSH. Furthermore, the drug reduced cellular
adhesion to the matrix, favoring the detachment and the
successive shrinkage of the cells; inhibited the binding of p65, a
component ofNF-kB, toDNA and caused phosphorylation and
activation of JNK. The conclusion that all these events were
determined by oxidative stress was supported by the evidence
Fig. 9. A: Parthenolide induces the release of cytochrome c from
mitochondria. MG63 and SK-MEL-28 cells (7T 106/100-mm culture
dish) were treated for 3 h with 25mM parthenolide and then
homogenized with a Dounce homogenizer. Subcellular fractionation
was performed as reported in Methods Section. Cytochrome c
content was assayed in mitochondrial and cytosolic fractions by
means of an ELISA procedure. B: The effect of parthenolide on
pro-caspase expression. MG63 and SK-MEL-28 cells (2T 105/well)
were treated for 3 and 5h with 25mM parthenolide. At the end
extracts were prepared and submitted to western blotting analysis in
order to ascertain the level of pro-caspases-3, -8, and -9 and their
possible cleavage forms. In (A) values are the means of three
independent experimentsWSE. MP<0.01 versus untreated control. In
(B) the results are representative of three independent experiments.
Fig. 10. A: Parthenolide induces the release of AIF from
mitochondria. MG63 and SK-MEL-28 cells (7T 106/100-mm culture
dish) were treated for 3 h with 25mM parthenolide and then
homogenized. Subcellular fractions were prepared as reported in
Methods Section. AIFwas analyzed bywestern blotting using 30mg of
proteins of each fraction. B: Parthenolide stimulates translocation of
AIF from the mitochondria to the nuclei and co-localization with
DNA. MG63 and SK-MEL-28 cells (6T 103/well) were treated for 3 h
with 25mM parthenolide and subjected to immunoﬂuorescence
analysis of AIF distribution using anti-AIF antibody and FITC-
conjugated secondary antibody (green ﬂuorescence). Nuclei were
stained with Hoechst 33342 (blue ﬂuorescence). The nuclear
translocation of AIF was shown by the merge of AIF and nuclear
staining. Fluorescent cells were visualized with a Leica DC 300F
microscope at 200T magniﬁcation with ﬂuorescent ﬁlters for FITC
andDAPI for AIF andHoechst, respectively. In (A) and (B) the results
are representative of three independent experiments.
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that they were prevented by the addition of anti-oxidants.
Moreover our conclusion was in agreement with the following
considerations: First, it is well known that ROS can oxidize
protein thiols (Zhang et al., 2004) while GSH depletion can
occur as a consequence of the involvement of GSH peroxidase
activity in the scavenge of ROS and other free radicals. Second,
ROS generation has been shown to inhibit adhesion of
mesenchymal stemcells (Song et al., 2010) and to induce cellular
shrinkage of Ehrlich ascites cells by activating KCl cotransport
(Lambert et al., 2009). Third, it has been suggested that ROS
generated by parthenolide can disrupt the NF-kB DNA binding
by either direct reactions or altering intracellular redox
(Shanmugam et al., 2010). Fourth, ROS can mediate JNK
activation inducing either apoptosis or necrosis (Shen and Liu,
2006; Shanmugam et al., 2010).
In addition it is interesting to note that oxidative stress and in
particular oxidation of both protein thiols (Petronilli et al.,
1994; McStay et al., 2002) and GSH (Costantini et al., 1996;
Halestrap et al., 1998) are involved in the control of
mitochondrial membrane potential, favoring the opening of the
PTP in the inner mitochondrial membrane with the consequent
mitochondrial depolarization. In accordance our results show
thatmitochondrial depolarizationwas completely abrogated by
NAC.
PTP plays a crucial role in the regulation of the decisive
events for the fate of the cells occurring in mitochondria, such
as production of ATP, calcium homeostasis, and programmed
cell death. PTP opening permits the passage of solutes with low
molecular weight into the matrix. Consequently the osmotic
pressure increases leading to the swelling of thematrix with the
rupture of the outer membrane and the passage of apoptotic
factors into the cytoplasm (Keinan et al., 2010). Instead the
inner membrane remains intact since it is larger than the outer
membrane. Furthermore, apoptotic factors can be also
released through VDAC after its oligomerization and
interaction with Bax. In this article mitochondrial membrane
potential (Dcm) was studied by using the ﬂuorescent dye JC-1,
which undergoes polymerization when Dcm is high. Our
results showed that parthenolide caused depolarization of
mitochondrial membrane. The effect was very rapid, since after
1–2 h of treatment, the ratio ‘‘red ﬂuorescence to green
ﬂuorescence,’’ which is in correlation with the polymerization
degree of JC-1, lowered to only 10–20% of the control value.
Mitochondrial depolarization was prevented by CsA, an
inhibitor of PTP opening (Javadov et al., 2009). Therefore PTP
opening with the consequent rupture of the outer
mitochondrial membrane seemed to be an important event in
the depolarization of mitochondrial membrane induced by
parthenolide. However, we concluded that also VDAC can be
involved in the dissipation of membrane potential, since
depolarization was also reduced by the inhibitor of VDAC
DIDS, although DIDS effect was minor than that observed with
CsA.
Furthermore our results suggest that a role in mitochondrial
depolarization is also exerted by calciumoverload since the loss
of Dcm was partially prevented by RU360, an inhibitor of the
inﬂux of Ca2þ into mitochondria.
It has been suggested that the extent of PTP opening is
fundamental to determine the modality of cell death. In fact
transient opening could be responsible for mitochondrial
swelling and the release of apoptotic factors, such as
cytochrome c and AIF, while ATP concentration can be not
affected. Instead extensive and persistent opening could lead to
a substantial ionic disturbancewith the loss of ATP, activation of
degradative enzymes, and cellular necrosis (McStay et al., 2002).
Our results demonstrate that after treatment with
parthenolide for 3–5 h most of cells were positive to Hoechst
and showed CC, while ATP concentration was not modiﬁed.
Instead mitochondrial depolarization for longer periods of
treatment (10–15 h) induced the fall in ATP content and
consequently the predominance of the necrotic signs.
Therefore most of cells exhibited PF, since they were positive
to both Hoechst and PI.
An important consequence of parthenolide-induced
depolarization of mitochondrial membrane consists in the
release of cytochrome c and/or AIF. Cytochrome c is usually
the responsible for the activation of caspase-dependent
apoptosis, while AIF mediates the activity of caspase-
independent program. This article shows that treatment with
parthenolide for 3 h induced the release from mitochondria of
both cytochrome c and AIF. Cytochrome c, when is released
into the cytosol, causes the production of apoptosomewith the
consequent activation of the initiator caspase-9, which in turn
stimulates the downstream caspase cascade. However, in our
experimental conditions although cytochrome c was released
from mitochondria the activation of caspase cascade did not
occur. This conclusion is based on the following ﬁndings:
western blotting analysis showed that parthenolide decreased
the level of pro-caspases-8 and -3 already after brief periods of
treatment, while the cleaved and active forms of caspases-8, -9,
and -3 were not produced during the entire treatment; the
decrement of ATP caused by parthenolide in the second period
is in contrast with the production of apoptosome; z-VAD-fmk
and other caspase inhibitors did not exert any effect on the
cytotoxic action of parthenolide. In addition our results are in
agreement with other reports showing that caspase activities
are strongly inhibited by oxidative stress (Samali et al., 1999).
Finally it has been reported that ERK 1/2, a kinase which is
Fig. 11. Depletion of AIF prevents the cytotoxic effect of
parthenolide. MG63 and SK-MEL-28 cells were transfected with
80 nMAIF siRNA, as reported inMethodsSection, andcomparedwith
cells transfected with 80nM scramble siRNA. A: Western blotting
analysis showing depletion of AIF in silenced cells. B: Depletion of AIF
diminished parthenolide effect on the production of both cells with
condensed chromatin (CCcells) andwith pinkﬂuorescence (PF cells).
AIF-silenced cells and control cells transfected with scramble
siRNA were treated for various times with 25mM parthenolide. At
the end the percentages of CC and PF cells were determined with
respect to the total number of cells. In (A) the results are
representative of three independent experiments. In (B) values are
the means of three independent experimentsWSE. MP<0.01 versus
scramble siRNA-transfected cells.
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activated by parthenolide, can suppress caspase-9 activity by
direct phosphorylationof an inhibitory site, Thr 125 (Allan et al.,
2003). Therefore, all these considerations led us to the
conclusion that parthenolide induces cell death through a
caspase-independent mechanism.
Differently from cytochrome c, AIF has been shown to
induce a caspase-independent mechanism in many
circumstances. However it is uncertain at themomentwhether
AIF is present in the intermembrane space (Sevrioukova, 2011)
or is inserted in the inner mitochondrial membrane (Arnoult
et al., 2002;Otera et al., 2005). In the ﬁrst case permeabilization
of the outer membrane could directly cause AIF release from
mitochondria, while in the second case the cleavage of the
protein by calpains is needed before AIF is released from
mitochondria (Polster et al., 2005). In both the cases AIF after
its release translocates to the nucleus where it contributes to
CC, high molecular weight DNA fragmentation, and nuclear
shrinkage (Susin et al., 2000; Dawson and Dawson, 2004; Hong
et al., 2004). Taken together our data strongly suggest that AIF
can be considered as an important mediator of cell death
induced by parthenolide. This conclusion is based on the
following evidences: First, immunoﬂuorescence permitted to
ascertain that after parthenolide treatment AIF co-localized in
the nuclei with condensed chromatin. Second, down-regulation
of AIF expression by speciﬁc siRNA markedly reduced the
cytotoxic effectiveness of parthenolide; in fact parthenolide
induced CC and fragmentation in a percentage of AIF-silenced
cells, which was much lower than that ascertained in the
control. A similar observation was also made for the cells
showing necrotic-like aspects, which appeared in the second
phase of treatment. Third, z-VAD-fmk was unable to prevent
both parthenolide-induced cell death and AIF translocation to
the nucleus. In addition observation that parthenolide
stimulated mitochondrial calcium uptake is in accordance with
the ﬁnding that Ca2þ can induce calpain-dependent cleavage of
AIF from the inner membrane (Norberg et al., 2008).
The results reported in this article demonstrate that
parthenolide rapidly caused dissipation of Dcm through ROS
generation. Depolarization of mitochondrial membrane
induced translocation of AIF to the nucleus (Pardo et al., 2001)
with the consequent condensation of chromatin and nuclear
shrinkage. These events occurred in the ﬁrst phaseof treatment
(0–5 h). In the second phase of treatment (5–15 h) the
content of ATP progressively lowered, reaching very low values
at 12–15 h. Therefore, necrotic aspects became gradually
prevalent and a high percentage of cells died for necrosis.
In conclusion this article shows that parthenolide induces cell
death in human MG63 and SK-MEL-28 cells by activating a
caspase-independent mechanism, which is mediated by AIF. In
particular AIF seems to be responsible not only for CC but also
for necrotic events. This is in accordance with recent reports
showing that AIF plays a key role in programmed necrosis by its
ability to organize a DNA-degrading complex (Artus et al., 2010;
Baritaud et al., 2010). Therefore, our article sheds new light on
the mechanism by which parthenolide induced death of tumor
cells and assigns to AIF the central role in the execution of this
caspase-independent mechanism of programmed cell death.
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